- Di processo
- Another important topic will be the impact of helicobacter pylori (h. Pylori), a major disruptor of gastrointestinal ecology. Emerging research will be presented on how h. Pylori eradication affects both gastrointestinal symptoms and the microbiome. Additionally, the congress will present a hands-on approach to managing common gastrointestinal symptoms and diseases where microbiome modulation proves to be an effective therapy. These include conditions such as diarrhea, constipation, ulcerative colitis, and drug-induced dysbiosis. The meeting will also explore the multidisciplinary approach for patients experiencing overlapping uro-gynecological symptoms.
- Professionali
- The growing significance of microbiome research has paved the way for a deeper understanding of the pathophysiology of gastrointestinal diseases and related disorders. The "microbiota road to" congress aims to delve into the impact of the microbiome on gastrointestinal health and explore its potential clinical implications. The 2025 edition will introduce groundbreaking insights into the role of intestinal barriers, which are crucial for overall health. Diet is one of the most significant factors influencing microbiome composition, and many patients with gastrointestinal issues often report symptom flare-ups after consuming specific foods. In this context, effectively managing food intolerances is key to enhancing patients' quality of life. The congress will also provide an in-depth examination of the utility of breath tests in gastroenterology, offering practical guidelines on which tests to use, when to use them, and how to interpret the results.
- Di sistema
- Finally, interactive clinical cases powered by artificial intelligence will challenge participants to develop microbiome-targeted diagnostic and therapeutic strategies, making this congress a truly immersive and practical learning experience.